Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
4
×
clinical trials
4
×
deals
4
×
life sciences
national blog main
national top stories
boston blog main
europe blog main
national
roche
san francisco blog main
san francisco top stories
amag pharmaceuticals
amgen
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
covid-19
crispr
detroit blog main
detroit top stories
editas medicine
europe top stories
fda
indiana blog main
indiana top stories
investing
ipo
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
What
bio
crispr
ipo
medicines
roundup
access
acquisitions
advanced
alliance
announced
bristol
buy
calls
cancer
capacity
car
cell
ceo
changing
collabs
color
consolidation
covid
daniel
days
deal
despite
drug
falcon
family
focus
gene
gilead
gilead’s
growing
hardest
help
hit
hottest
hours
Language
unset
4
×
Current search:
deals
×
" clinical trials "
×
unset
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
